comparemela.com

Latest Breaking News On - Otsuka america pharmaceuticals inc - Page 2 : comparemela.com

OptimizeRx Appoints Seasoned Financial and Operational

OptimizeRx Appoints Seasoned Financial and Operational
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Japan
Rochester
Japanese
American
Doug-baker
Edward-stelmakh
American-foundation-for-suicide-prevention
Company-nasdaq
Arts-council-of-princeton
Otsuka-america-pharmaceuticals-inc

OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief ...

OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief ...
kulr8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kulr8.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Japan
Rochester
Japanese
American
Doug-baker
Andy-dsilva
Maira-alejandra
Optimizerx
Edward-stelmakh
American-foundation-for-suicide-prevention

OptimizeRx Appoints Seasoned F - GuruFocus.com

OptimizeRx Appoints Seasoned F - GuruFocus.com
gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Japan
Rochester
Japanese
American
Doug-baker
Andy-dsilva
Maira-alejandra
Ashley-robinson
Edward-stelmakh
American-foundation-for-suicide-prevention

PsyBio Therapeutics Appoints Pharmaceutical Veteran Bob Oliver to its Board of Directors

PsyBio Therapeutics Appoints Pharmaceutical Veteran Bob Oliver to its Board of Directors Mr. Oliver joins PsyBio bringing over 25 years of executive pharmaceutical experience having held various senior positions at Otsuka, Wyeth and Johnson & Johnson News provided by Share this article Share this article PsyBio or the Company ), a biotechnology company pioneering the next generation of targeted psychoactive medications, is pleased to announce the appointment of Mr. Bob Oliver to the Company s board of directors (the Board ), effective immediately. The Company is developing a platform technology that produces tryptamines, such as psilocybin and its intermediates, for intended therapeutic use. Mr. Oliver has extensive experience in launching pharmaceutical products into global markets offering  invaluable depth to our team.

Ohio
United-states
Canada
Americans
America
Canadian
Tim-regan
Michael-jordan
Gerald-goldberg
Bob-oliver
Evan-levine
John-legend

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.